NASDAQ : INGN

Inogen, Inc.

$6.02 USD

-$0.03 (-0.5%)

Volume
272.05K
Average Volume
304.79K
Market Capitalization
$162.99M
P/E Ratio
-6.69
Dividend Yield
0.00%
Price Target
$26.00
Year High
$9.13
Year Low
$5.34
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$2.74
Company Overview

NASDAQ

Kevin R. Smith

Medical - Devices

Healthcare

INGN

753

US

USD

https://www.inogen.com

805 562 0500

45780L104

0001294133

Liquidity Metrics

0.09

2.74

2.34

1.23

0.00

Sales & Valuation

$348.67M

0.46

0.93

-23.32

-0.26

Profitability

-$0.85

-$22.75M

-6.94%

-7.14%

-13.17%

-8.61%

P/E Metrics

-6.69

-0.46

-0.46

Analyst Price Target & Rating

$26.00

$26.00

$26.00

Sell

2/5

11 Analysts

-76.85%

Financial Health Scores

1.48

2/9

$123.27M

$285.57M

$110.71M

-$21.49M

Key Metrics (TTM)

$92.32M

0.26

-8.21

2.74

-13.17%

-13.35%

-14.96%

-4.27%

104 days

Company Executives
Name Title
Andrew Reding Executive VP & COO
Kevin Smith General Counsel, Secretary & Executive Vice President of Business Development
Kevin R. Smith President, Chief Executive Officer & Director
Jennifer Yi Boyer Executive Vice President of Enterprise Enablement & Chief Human Resources Officer
Lorna Williams Senior Vice President of Investor Relations
Dominic Hulton Chief Marketing Officer
Grgoire Ramade Executive Vice President & Chief Commercial Officer
Naga Rameswamy Chief Technology Officer
Michael J. Bourque Advisor
Mary Wright VP & Chief Accounting Officer
Philip Corrin Senior Vice President of Operations & Supply Chain
Jason A. Richardson CFO, Executive VP & Treasurer
Poll Results

No votes yet today — be the first to share your view!

About Inogen, Inc. (NASDAQ:INGN) Stock

Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions. The company's diverse product range features the popular portable Inogen One, which efficiently draws oxygen from the surrounding atmosphere to offer an independent supply, alongside stationary Inogen At Home concentrators, Tidal Assist Ventilators, and various associated accessories. Inogen serves a broad clientele, including individual patients, medical professionals, and insurance providers, both domestically in the United States and globally. Furthermore, the company facilitates direct equipment rentals to patie ... nts. Founded in 2001, Inogen, Inc. is headquartered in Goleta, California.

Inogen Q2 Earnings Beat Estimates, Sales Rise Y/Y, 2026 View Cut

2026-08-10 13:56:03

INGN's Q2 revenues rise 3% as international sales climb 14.8%, but U.S. weakness led it to cut its 2026 revenue outlook.

Inogen, Inc. (INGN) Q2 2026 Earnings Call Transcript

2026-08-07 10:24:24

Inogen, Inc. (INGN) Q2 2026 Earnings Call Transcript

Inogen Q2 Earnings Call Highlights

2026-08-06 23:04:36

Inogen NASDAQ: INGN reported second-quarter 2026 revenue of $95.1 million, up 3% from a year earlier, as international growth, portable oxygen concentrator demand and contributions from newer products offset continued pressure in its U.S. direct-to-consumer business.

Inogen (INGN) Reports Q2 Loss, Tops Revenue Estimates

2026-08-06 20:13:24

Inogen (INGN) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.15 per share a year ago.

Inogen Announces Second Quarter 2026 Financial Results

2026-08-06 16:05:00

BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Reported second quarter revenue of $95.1 million. Company raises full-year adjusted EBITDA guidance to approximately $4.0 million.

Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026

2026-07-16 08:30:00

BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026.

Inogen Announces the Appointment of Andy Reding as Chief Operating Officer

2026-07-01 16:05:00

BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Announces the Appointment of Andy Reding as Chief Operating Officer.

Here's Why You Should Retain Inogen Stock in Your Portfolio for Now

2026-06-25 11:16:05

INGN's POC strength, expanding respiratory portfolio and international momentum support growth, though U.S. revenue pressure remains a key risk.

Frequently Asked Questions

What is the current Inogen, Inc. (INGN) stock price?

Inogen, Inc.(NASDAQ:INGN) stock price is $6.02 in the last trading session. During the trading session, INGN stock reached the peak price of $9.13 while $5.34 was the lowest point it dropped to. The percentage change in INGN stock occurred in the recent session was --0.5% while the dollar amount for the price change in INGN stock was -$0.03.

INGN's industry and sector of operation?

The NASDAQ listed INGN is part of Medical - Devices industry that operates in the broader Healthcare sector.

Who are the executives of INGN?

Andrew Reding | Executive VP & COO
Kevin Smith | General Counsel, Secretary & Executive Vice President of Business Development
Kevin R. Smith | President, Chief Executive Officer & Director
Jennifer Yi Boyer | Executive Vice President of Enterprise Enablement & Chief Human Resources Officer
Lorna Williams | Senior Vice President of Investor Relations

How many employees does INGN have?

Number of INGN employees currently stands at 753. INGN operates from 500 Cummings Center, Beverly, MA 01915, US.

Link for INGN official website?

Official Website of INGN is: https://www.inogen.com

How do I contact INGN?

INGN could be contacted at phone #805 562 0500 and can also be accessed through its website. INGN operates from 500 Cummings Center, Beverly, MA 01915, US.

How many shares of INGN are traded daily?

The average number of INGN shares traded daily for last 3 months was 304.79K.

What is the market cap of INGN currently?

The market value of INGN currently stands at $162.99M with its latest stock price at $6.02